MedTrace Logo

Integrated Short-Term Palliative Rehabilitation in Incurable Cancer

NCT05984797 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 340

Last updated 2024-05-22

No results posted yet for this study

Summary

The goal of this intervention trial is to determine if palliative rehabilitation in addition to usual care is more effective than usual care at improving health-related quality of life in patients with incurable solid cancer.

Conditions

Interventions

OTHER

Integrated Short-term Palliative Rehabilitation

Participants will be offered up to 3 manualised sessions (face to face and/or remotely, via telephone or video-conference) delivered by an expert rehabilitation practitioner (physiotherapist, occupational therapist,). Core components focus on (i) self-management of symptoms, (ii) physical activities and fitness, and (iii) social participation. Delivery of rehabilitation intervention components will include explicit use of behaviour change techniques including goal setting and action planning to focus on outcomes that are meaningful for the person, their family, and clinicians.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    collaborator OTHER

  • University of Bergen

    collaborator OTHER

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    collaborator OTHER

  • Research Unit for General Practice, Aarhus University

    collaborator OTHER

  • University of Edinburgh

    collaborator OTHER

  • EAPC

    collaborator UNKNOWN

  • Azienda USL - IRCCS di Reggio Emilia

    collaborator UNKNOWN

  • King's College London

    lead OTHER

Principal Investigators

  • Matthew Maddocks · KCL

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-18
Primary Completion
2025-10-02
Completion
2026-08-31

Countries

  • Denmark
  • France
  • Italy
  • Norway
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05984797 on ClinicalTrials.gov